Pharsight

VERTEX PHARMACEUTICALS INC patents facing oppositions

Top patents of VERTEX PHARMACEUTICALS INC facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3345625B1 09 Dec, 2020 Pharmaceutical composition and administrations thereof Aug, 2029 3
EP3880197B1 22 Feb, 2023 Methods of treatment for cystic fibrosis Nov, 2039 2
EP3752510B1 07 Dec, 2022 Macrocycles as modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions thereof, their use in the treatment of cycstic fibrosis, and process for making them Feb, 2039 1
EP3798214B1 14 Sep, 2022 Modulators of cystic fibrosis transmembrane conductance regulator Oct, 2035 1
EP3203840B1 05 Aug, 2020 Modulators of cystic fibrosis transmembrane conductance regulator Oct, 2035 1
EP2464337B1 09 Jan, 2019 Pharmaceutical composition and administrations thereof NA 1
EP2914248B2 05 Sep, 2018 Pharmaceutical compositions for the treatment of cftr mediated diseases NA 1
EP3131582B1 23 May, 2018 Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases NA 1